arBtrage CAPITALIZING MARKETS checking… Sign in

Larimar Therapeutics, Inc.

LRMR Health Care Biotechnology: Pharmaceutical Preparations
$3.17
▼ -3.6% Today
as of Jun 7, 07:20 ET
Last 30 days -27.95% Apr 28 → Jun 05
$3.07 $3.43 $3.79 $4.14 $4.50 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$3.25
High
$3.25
Low
$3.12
Volume
$1M
Avg Vol
$2M
Mkt Cap
$363M
P/E (TTM)
Beta
52w High
$6.42
52w Low
$2.22
Div Yield
Shares Out
$104M

Overview

52-week range
$2.22
$6.42
23% of range
Avg surprise (last 2)
+16.0%
Avg reaction (last 2)
+2.9%
50% positive
Latest IV / EM
80%
EM ±11.0% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.61$-0.51$-0.40$-0.29$-0.19 Actual $-0.19Actual $-0.21Actual $-0.27Actual $-0.34Actual $-0.24Actual $-0.46Est $-0.42Actual $-0.41Actual $-0.61Actual $-0.31Est $-0.53 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-48M$-40M$-32M$-24M$-16M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.31 $-0.53 +41.5% +32.6% -5.1% earnings
Tue Sep 30, 2025Sep 2025 $-0.61 financials
Mon Jun 30, 2025Jun 2025 $-0.41 financials
Wed Apr 30, 2025Mar/2025 $-0.46 $-0.42 -9.5% +10.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.24 financials
Sun Jun 30, 2024Jun 2024 $-0.34 financials
Sun Mar 31, 2024Mar 2024 $-0.27 financials
Sat Sep 30, 2023Sep 2023 $-0.21 financials
Fri Jun 30, 2023Jun 2023 $-0.19 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-31M$-49M$-28M$-31M$-18M$-25M
Net income$-30M$-48M$-26M$-29M$-15M$-22M
EPS (diluted)$-0.61$-0.41$-0.46$-0.24$-0.34

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$178M$85M$90M$21M$21M$33M$35M$32M
Inventory
Total current assets$205M$142M$183M$146M$165M$195M$213M$231M
Total assets$209M$146M$187M$150M$170M$200M$219M$237M
Long-term debt
Total liabilities$50M$68M$48M$30M$26M$28M$21M$26M
Total equity$158M$78M$139M$120M$144M$172M$198M$211M

Implied volatility — last 90 days

74%77%79%82%84% Jun 07 — IV 80% · EM ±11.0%

Sector peers